204 related articles for article (PubMed ID: 35611941)
1. MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.
Phillips E; Ahmad N; Sun L; Iben J; Walkey CJ; Rusin A; Yuen T; Rosen CJ; Willis IM; Zaidi M; Johnson DL
Elife; 2022 May; 11():. PubMed ID: 35611941
[TBL] [Abstract][Full Text] [Related]
2. Maf1 and Repression of RNA Polymerase III-Mediated Transcription Drive Adipocyte Differentiation.
Chen CY; Lanz RB; Walkey CJ; Chang WH; Lu W; Johnson DL
Cell Rep; 2018 Aug; 24(7):1852-1864. PubMed ID: 30110641
[TBL] [Abstract][Full Text] [Related]
3. Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2.
Sun Y; Chen C; Xue R; Wang Y; Dong B; Li J; Chen C; Jiang J; Fan W; Liang Z; Huang H; Fang R; Dai G; Yan Y; Yang T; Li X; Huang ZP; Dong Y; Liu C
Theranostics; 2019; 9(24):7268-7281. PubMed ID: 31695767
[No Abstract] [Full Text] [Related]
4. Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression.
Rohira AD; Chen CY; Allen JR; Johnson DL
J Biol Chem; 2013 Jun; 288(26):19288-95. PubMed ID: 23673667
[TBL] [Abstract][Full Text] [Related]
5. Regulation of RNA polymerase III transcription by Maf1 in mammalian cells.
Goodfellow SJ; Graham EL; Kantidakis T; Marshall L; Coppins BA; Oficjalska-Pham D; Gérard M; Lefebvre O; White RJ
J Mol Biol; 2008 May; 378(3):481-91. PubMed ID: 18377933
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase II-mediated phosphorylation of general repressor Maf1 triggers RNA polymerase III activation.
Graczyk D; Debski J; Muszyńska G; Bretner M; Lefebvre O; Boguta M
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4926-31. PubMed ID: 21383183
[TBL] [Abstract][Full Text] [Related]
7. Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases.
Johnson SS; Zhang C; Fromm J; Willis IM; Johnson DL
Mol Cell; 2007 May; 26(3):367-79. PubMed ID: 17499043
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells.
Shor B; Wu J; Shakey Q; Toral-Barza L; Shi C; Follettie M; Yu K
J Biol Chem; 2010 May; 285(20):15380-15392. PubMed ID: 20233713
[TBL] [Abstract][Full Text] [Related]
9. Metabolic programming a lean phenotype by deregulation of RNA polymerase III.
Willis IM; Moir RD; Hernandez N
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12182-12187. PubMed ID: 30429315
[TBL] [Abstract][Full Text] [Related]
10. Maf1, a new player in the regulation of human RNA polymerase III transcription.
Reina JH; Azzouz TN; Hernandez N
PLoS One; 2006 Dec; 1(1):e134. PubMed ID: 17205138
[TBL] [Abstract][Full Text] [Related]
11. MAF1 is a chronic repressor of RNA polymerase III transcription in the mouse.
Bonhoure N; Praz V; Moir RD; Willemin G; Mange F; Moret C; Willis IM; Hernandez N
Sci Rep; 2020 Jul; 10(1):11956. PubMed ID: 32686713
[TBL] [Abstract][Full Text] [Related]
12. Recovery of RNA polymerase III transcription from the glycerol-repressed state: revisiting the role of protein kinase CK2 in Maf1 phosphoregulation.
Moir RD; Lee J; Willis IM
J Biol Chem; 2012 Aug; 287(36):30833-41. PubMed ID: 22810236
[TBL] [Abstract][Full Text] [Related]
13. Two steps in Maf1-dependent repression of transcription by RNA polymerase III.
Desai N; Lee J; Upadhya R; Chu Y; Moir RD; Willis IM
J Biol Chem; 2005 Feb; 280(8):6455-62. PubMed ID: 15590667
[TBL] [Abstract][Full Text] [Related]
14. The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis.
Wang X; Rusin A; Walkey CJ; Lin JJ; Johnson DL
J Biol Chem; 2019 Dec; 294(50):19255-19268. PubMed ID: 31645432
[TBL] [Abstract][Full Text] [Related]
15. Facilitated recycling protects human RNA polymerase III from repression by Maf1 in vitro.
Cabart P; Lee J; Willis IM
J Biol Chem; 2008 Dec; 283(52):36108-17. PubMed ID: 18974046
[TBL] [Abstract][Full Text] [Related]
16. MAF1 represses CDKN1A through a Pol III-dependent mechanism.
Lee YL; Li YC; Su CH; Chiao CH; Lin IH; Hsu MT
Elife; 2015 Jun; 4():e06283. PubMed ID: 26067234
[TBL] [Abstract][Full Text] [Related]
17. Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription.
Upadhya R; Lee J; Willis IM
Mol Cell; 2002 Dec; 10(6):1489-94. PubMed ID: 12504022
[TBL] [Abstract][Full Text] [Related]
18. Diurnal regulation of RNA polymerase III transcription is under the control of both the feeding-fasting response and the circadian clock.
Mange F; Praz V; Migliavacca E; Willis IM; Schütz F; Hernandez N;
Genome Res; 2017 Jun; 27(6):973-984. PubMed ID: 28341772
[TBL] [Abstract][Full Text] [Related]
19. Maf1 limits RNA polymerase III-directed transcription to preserve genomic integrity and extend lifespan.
Noguchi C; Wang L; Shetty M; Mell JC; Sell C; Noguchi E
Cell Cycle; 2021 Feb; 20(3):247-255. PubMed ID: 33475456
[TBL] [Abstract][Full Text] [Related]
20. Maf1 phenotypes and cell physiology.
Willis IM
Biochim Biophys Acta Gene Regul Mech; 2018 Apr; 1861(4):330-337. PubMed ID: 29248739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
